4
Changes in Ownership
Attovia Therapeutics, Inc. Filed Acc 0001231919-26-000838
10% owner bought 588,235 shares at $17.00 ($9,999,995)
- 10% owner acquired 5,490,629 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Frazier Life Sciences XI, L.P. 10% owner | 2026-08-06 | Conversion | +1,749,192 | 1,824,541 | D | ||
| Frazier Life Sciences XI, L.P. 10% owner | 2026-08-06 | Conversion | +1,590,175 | 3,414,716 | D | ||
| Frazier Life Sciences XI, L.P. 10% owner | 2026-08-06 | Conversion | +1,189,940 | 4,604,656 | D | ||
| Frazier Life Sciences XI, L.P. 10% owner | 2026-08-06 | Conversion | +961,322 | 5,565,978 | D | ||
| Frazier Life Sciences XI, L.P. 10% owner | 2026-08-06 | Purchase | +588,235 | $17.00 | $9,999,995 | 6,154,213 | D |
| Derivatives | |||||||
| Frazier Life Sciences XI, L.P. 10% owner | 2026-08-06 | Conversion · Series A-1 Preferred Stock | −16,250,000 | 0 | D | ||
| Frazier Life Sciences XI, L.P. 10% owner | 2026-08-06 | Conversion · Series A-2 Preferred Stock | −14,772,727 | 0 | D | ||
| Frazier Life Sciences XI, L.P. 10% owner | 2026-08-06 | Conversion · Series B Preferred Stock | −11,054,544 | 0 | D | ||
| Frazier Life Sciences XI, L.P. 10% owner | 2026-08-06 | Conversion · Series C Preferred Stock | −8,930,685 | 0 | D | ||
| Open-market purchases · 588,235 sh · avg $17.00 · $9,999,995 | |||||||
Loading xslF345X06/form4-08062026_090845.xml…